or
forgot password

    • cancer clinical trials in mentor, OH

    • Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Lake University Seidman Cancer Center
    Mentor, Ohio 44060
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer, Sarcoma
    Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Vulvar Cancer
    Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Gestational Trophoblastic Tumor
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer
    Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
    UH-LUICC
    Mentor, Ohio 44060
    Breast Cancer
    Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage II Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Gestational Trophoblastic Tumor
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Sarcoma
    Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Breast Cancer
    Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Lung Cancer
    Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Cervical Cancer, Precancerous Condition
    Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
    UH-LUICC
    Mentor, Ohio 44060
    Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Psychosocial Effects of Cancer and Its Treatment
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lapatinib Resistance in Patients With Breast Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Breast Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    BIBF 1120 in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Endometrial Cancer
    Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Localized Unresectable Adult Primary Liver Cancer, Periampullary Adenocarcinoma, Recurrent Adult Primary Liver Cancer, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    Lake University Ireland Cancer Center
    Mentor, Ohio 44060
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
    Lake/University Ireland Cancer Center
    Mentor, Ohio 44060
    Cervical Cancer